1. Systemic Lupus Erythematosus

2. Systemic Lupus Erythematosus

3. Patient Case 1

4. Further Workup

5. Renal Biopsy

6. Tubulointerstitial Disease Has High Impact on Prognosis: Rarely Seen in Pure Class ll or V

7. Renal Biopsy (cont)

8. Further Workup

9. Standardized Mortality Ratio in SLE

10. Patient Case 1 (cont)

11. ACR Guidelines for Nephritis Treatment

12. Multitarget Induction Therapy for Lupus Nephritis

13. Voclosporin, a Novel Calcineurin Inhibitor: Phase 2 Lupus Nephritis Study

14. Efficacy and Safety of Belimumab in Active Lupus Nephritis: BLISS-LN

15. Influence of Race/Ethnicity on Response to LN Treatment: The ALMS Study

16. Discussion: Team-Based Approach

17. The 18-Minute Consult

18. 20th-Century Provider

19. Patient Case 2

20. Relevant Physical Examination Findings

21. Relevant Laboratory Findings Within 24 Hours of Hospitalization

22. Hospital Stay

23. Thrombotic Microangiopathic Hemolytic Anemia

24. Treatments for Acquired TTP/Autoimmune TMHA

25. Role of Primary Care Team

26. Long-Term Follow-Up With Primary Care

27. Effective Communication

28. Patient Case 3

29. Patient Case 3 (cont)

30. Patient Case Relevant Physical Exam Findings

31. Patient Case Relevant Laboratory Findings

32. Group Discussion

33. Fatigue in SLE

34. Patient Case Workup

35. Nonpharmacologic Options

36. Pharmacologic Options for Fatigue and Malaise

37. Other Considerations for Primary Care Support

38. Abbreviations

39. Abbreviations (cont)

40. Abbreviations (cont)